SUBSCRIBE
Drivetime Radio

Listen to our experienced medical broadcasters, moderating engaging and educational discussions with leading experts and key opinion leaders. Each interview is ~10 minutes, so you can listen anywhere, anytime, to stay up-to-date on the go. Continuing professional development is also available for this program, click on the ‘accreditation points icon’ for further details. Interviews are provided exclusively for healthcare professionals, available online, via podcast, and complimentary audio CD.

Subscribe with us directly for your chance to win an Apple Watch or Fitbit Versa. We will draw the winners on Wednesday 27th December 2023! This offer is only available for NEW subscribers. Click here for full terms and conditions.

Search Interviews

By area of interest:

Medical Interviews

E158.1The newly established National Hypertension Taskforce of Australia – who, why, & how? 28 minute listen
00:00
Preview
10 seconds
Show more information

Tackling Hypertension Head-On – Miniseries, Part 1: Raised blood pressure is the leading cause of death in the world resulting in almost 11 million deaths each year, or 30,000 deaths each day, and here in Australia, it is also the leading risk factor for death, yet 68% of people with hypertension are uncontrolled. The good news is, we have an excellent healthcare system, so there is really no reason why we cannot improve substantially to become among the best in the world in hypertension care! In part one of this series we discuss the goals of the newly established National Hypertension Taskforce of Australia, strategies for managing resistant hypertension, key issues of medication adherence, and new treatment options.

Hosted by

Prof Alta Schutte

Interviewees

  • Prof. Markus Schlaich, a Nephrologist & Hypertension Specialist from Perth, Prof. Markus Schlaich, a Nephrologist & Hypertension Specialist from Perth,
  • Dr Michael Rakotz, an assistant clinical professor of family and community medicine at Northwestern’s Feinberg School of Medicine, Illinois, US, and member of the international advisory to the Australian Taskforce.Dr Michael Rakotz, an assistant clinical professor of family and community medicine at Northwestern’s Feinberg School of Medicine, Illinois, US, and member of the international advisory to the Australian Taskforce.
E157.4What’s new with pacemakers? (11 Mins)
00:00
Preview
10 seconds
Show more information
Pacemaker therapy for bradyarrhythmias is well established, with around 20,000 cardiac rhythm management devices implanted each year in Australia. It can be difficult to stay up to date with the constantly evolving cardiac device technology. Leadless pacemakers are one of the newer devices becoming available and in this interview, we are looking at how they compare with traditional transvenous pacemakers, and what to consider when referring your patients for pacemaker therapy.

 

Hosted by

Dr Ginni Mansberg

Interviewees

  • Dr Michael Wong, Cardiologist & Electrophysiologist, Knox Private Hospital, Wantirna, VictoriaDr Michael Wong, Cardiologist & Electrophysiologist, Knox Private Hospital, Wantirna, Victoria
E157.3Lipid targets, what’s good enough? (14 mins)
00:00
Preview
10 seconds
Show more information

While survival rates for cardiovascular disease have improved over the past 50 years, it remains the biggest killer, and the most expensive group of diseases to treat in Australia. Although there is clear evidence now that elevated low-density lipoprotein (LDL) cholesterol is a major contributor to significant cardiovascular events, there remains a large unmet need for better lipid control. Many patients are either not receiving any lipid-lowering therapy, and for those being treated, almost half are not at target. In this interview, we are looking at the importance of optimal lipid management to minimise the risk of cardiovascular events.

The Baker Heart and Diabetes Institute miniseries, produced to support GPs in the diagnosis, prevention, and treatment of diabetes and cardiovascular disease.

Hosted by

Dr Anita Sharma

Interviewees

  • Prof. Stephen Nicholls, a Cardiologist from Monash University, Melbourne.Prof. Stephen Nicholls, a Cardiologist from Monash University, Melbourne.
E157.2The importance of managing iron levels throughout pregnancy (13 mins)
00:00
Preview
10 seconds
Show more information

Miniseries: Micronutrients during the first 1000 days of a child’s life, from conception through the first two years. Part 3: In this interview, we are exploring the impact of pregnancy on maternal iron demands as well as the factors that affect iron absorption and metabolism. While iron supplementation is not routinely recommended for all pregnant women, there are known risk factors for becoming deficient during pregnancy. We unpack strategies to identify and prevent iron deficiency and iron deficiency anaemia in pregnancy.

Hosted by

Dr Ginni Mansberg

Interviewees

  • A/Prof. Treasure McGuire, Pharmacist, Pharmacologist, Educator & Researcher, University of Queensland & Bond UniversityA/Prof. Treasure McGuire, Pharmacist, Pharmacologist, Educator & Researcher, University of Queensland & Bond University
E157.1Menopause miniseries, Part 2: Menopause is a huge process, it’s a brain problem as well as a body problem. (15 mins)
00:00
Preview
10 seconds
Show more information

In this interview we are discussing mental health during the menopause transition, which is a “window of vulnerability” for the development of menopausal associated depression in some women. Studies show that the incidence of depression in middle-aged women is between 20 and 30%. Depressive symptoms may develop or become more severe during the time of dynamic hormonal changes, so as GPs we need to listen to our female patients, and make sure we consider the underlying causes, like menopause, with the middle-aged woman.

Hosted by

Dr Ginni Mansberg

Interviewees

  • Prof. Jayashri Kulkarni, Professor of Psychiatry, The Alfred and Monash University, and founder of the Australian Consortium for Women’s Mental Health in Melbourne.Prof. Jayashri Kulkarni, Professor of Psychiatry, The Alfred and Monash University, and founder of the Australian Consortium for Women’s Mental Health in Melbourne.
E156.5The highs and lows of glycaemic management in type 2 diabetes (12 mins)
00:00
Preview
10 seconds
Show more information

A diagnosis of type 2 diabetes (or even prediabetes) can be overwhelming for patients, with a steep learning curve as they find out about lifestyle changes, glucose monitoring and medication. With so much to consider, it’s hardly surprising that less than half of patients with type 2 diabetes actually adhere to dietary recommendations. Evidence shows that medical nutrition therapy improves glycaemic control and reduces the risks of diabetes and its complications. So how can we help our patients realise the benefits of nutrition therapy, especially when the majority of us do not have enough time to provide detailed nutrition advice?

Hosted by

Dr Ginni Mansberg

Interviewees

  • A/Prof. Sof Andrikopoulos, Endocrinologist, CEO of Australian Diabetes Society	A/Prof. Sof Andrikopoulos, Endocrinologist, CEO of Australian Diabetes Society
E156.4Muscles matter (14 mins)
00:00
Preview
10 seconds
Show more information

As GPs we are in the hot seat for assessment of each patients’ individual combination of risk factors and pathology, providing lifestyle advice and managing metabolic and cardiovascular risk. In Australia, 25 years of preventative health has seen improvements in the outcomes of cardiovascular disease and cancer, and our patients are living longer. But with evidence showing that chronic sarcopenia is linked to disability and mortality, do we give muscle health the attention it deserves?

Hosted by

Dr Ginni Mansberg

Interviewees

  • Prof. Simon Willcock, General Practitioner, Clinical Program Head of Primary and Generalist Care, Wellbeing and Diagnostics, MQ HealthProf. Simon Willcock, General Practitioner, Clinical Program Head of Primary and Generalist Care, Wellbeing and Diagnostics, MQ Health
E156.3IBS miniseries, Part 3: Empowering patients to gain control of their symptoms (11 mins)
00:00
Preview
10 seconds
Show more information

Irritable bowel syndrome (IBS), is one of several highly prevalent multi-symptom functional gastrointestinal disorders (FGIDs) that has a wide clinical spectrum. Patients suffering from IBS and FGID symptoms often find it impacts their daily life, affects their quality of life, and even upsets their work. In this final interview in the series, we discuss the management options available, including evidence-based treatments, dietary therapy and psychological therapies.

Hosted by

Dr Brad McKay

Interviewees

  • A/Prof. Rebecca Burgell, Head of the Functional Gastrointestinal Disorders Service, The Alfred Hospital in Melbourne.A/Prof. Rebecca Burgell, Head of the Functional Gastrointestinal Disorders Service, The Alfred Hospital in Melbourne.
E156.2IBS miniseries, Part 2: No two patients should be expected to have the same disease – Why? (13 mins)
00:00
Preview
10 seconds
Show more information

Irritable bowel syndrome, or IBS, is a complex condition with many different causes and clinical presentations. IBS typically causes abdominal pain, bloating and distension with unpredictable bowel actions including constipation, diarrhoea, or a combination of both.  Now although we still don’t know the exact cause of IBS, researchers are beginning to piece together this incredibly complicated puzzle, listen to learn more….

Hosted by

Dr Brad McKay

Interviewees

  • Dr Simona Carbone, an Australian Research Council DECRA Fellow at Monash University.Dr Simona Carbone, an Australian Research Council DECRA Fellow at Monash University.
E156.1IBS miniseries, Part 1: The critical importance of an early, clear, clinical diagnosis (12 Mins)
00:00
Preview
10 seconds
Show more information
Irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGIDs) are highly prevalent conditions, with IBS alone affecting 10% of the Australian population at any point in time. FGIDs and IBS can result in significant disability, reduced quality of life and impaired workforce productivity. Despite the high prevalence of these conditions, they do not appear to be generally well handled within the health care system, which leads to the frustration and dissatisfaction in patients and doctors alike. This frustration appears to begin with the diagnostic process and flows through to either insufficient or excess investigations and repeat consultations and re-investigations. In this interview we present the first of a series of three interviews looking at the diagnosis, patient experience, and management of IBS and FGIDs.

 

Hosted by

Dr Brad McKay

Interviewees

  • Prof. Geoffrey Hebbard, Director of Gastroenterology and Hepatology at The Royal Melbourne Hospital.Prof. Geoffrey Hebbard, Director of Gastroenterology and Hepatology at The Royal Melbourne Hospital.

Search Interviews

By area of interest:

Exclusively for Australian healthcare professionals
×

Tap the share icon ios share icon and select 'Add to Home Screen' to add the site to your home screen for quick access!